CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Pharma
Original article

FMC Corporation reports second quarter 2026 results with Adjusted EBITDA above high end of guidance range and solid cash generation

EarningsNegative
AI Analysis

Summary

FMC Corporation reported Q2 2026 revenue of $867 million, down 17% year-over-year, with Adjusted EBITDA above guidance but updated full-year outlook due to challenging macroeconomic conditions.

Financial Highlights

Revenue

$867 million

Guidance

full-year outlook updated to reflect more challenging macro environment

Importance:4/10
Sentiment:
-0.30
earningsQ2 2026revenue declineguidance update
Related Companies

Read the original article

Published by PR Newswire Pharma on July 29, 2026 8:30 PM

Read Original